LPL Financial
SCMP

LPL Financial’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

LPL Financial’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-55,600
Closed -$776K – 2859
2016
Q4 		$776K Buy
+55,600
New +$776K 0.01% 1384
2016
Q1 		– Sell
-100,604
Closed -$1.62M – 3254
2015
Q4 		$1.62M Buy
100,604
+63,446
+171% +$1.14M ﹤0.01% 1314
2015
Q3 		$791K Buy
+37,158
New +$852K ﹤0.01% 1417

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's SCMP Position: Q1 2017 in Review

LPL Financial sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2017, closing a stake of 55,600 shares — an estimated $776K sold.

LPL Financial first reported a position in SCMP in Q3 2015 and held it in 3 quarters. The position peaked at $1.62M in Q4 2015. 167 funds tracked by Wall St. Rank hold SCMP as of Q1 2017.

  • LPL Financial reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • LPL Financial sold 55,600 Sucampo Pharmaceuticals, Inc. shares in Q1 2017, an estimated $776K.
  • LPL Financial first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • LPL Financial's Sucampo Pharmaceuticals, Inc. position peaked at $1.62M in Q4 2015.
  • 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2017.

Based on LPL Financial's 13F filing for Q1 2017, filed 15 May 2017.